Pandey, K.; Lee, E.; Park, N.; Hur, J.; Cho, Y.B.; Katuwal, N.B.; Kim, S.K.; Lee, S.A.; Kim, I.; An, H.J.;
et al. Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics. Genes 2021, 12, 159.
https://doi.org/10.3390/genes12020159
AMA Style
Pandey K, Lee E, Park N, Hur J, Cho YB, Katuwal NB, Kim SK, Lee SA, Kim I, An HJ,
et al. Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics. Genes. 2021; 12(2):159.
https://doi.org/10.3390/genes12020159
Chicago/Turabian Style
Pandey, Kamal, Eunbyeol Lee, Nahee Park, Jin Hur, Young Bin Cho, Nar Bahadur Katuwal, Seung Ki Kim, Seung Ah Lee, Isaac Kim, Hee Jung An,
and et al. 2021. "Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics" Genes 12, no. 2: 159.
https://doi.org/10.3390/genes12020159
APA Style
Pandey, K., Lee, E., Park, N., Hur, J., Cho, Y. B., Katuwal, N. B., Kim, S. K., Lee, S. A., Kim, I., An, H. J., Hwang, S., & Moon, Y. W.
(2021). Deregulated Immune Pathway Associated with Palbociclib Resistance in Preclinical Breast Cancer Models: Integrative Genomics and Transcriptomics. Genes, 12(2), 159.
https://doi.org/10.3390/genes12020159